...FH.,151 respondents (40.5%) reported having patients under their care who would meet the diagnostic criteria for FH, but...
...FH) or non-FH at high cardiovascular risk who require additional pharmacological management to achieve their LDL-C treat...
...FH-related proteins FHR1 and FHR3. High levels of autoantibodies, noted at the onset of disease and during relapses, ind...
...FH and as soon as the diagnosis of heterozygous FH is made in adults. Combination therapy is often necessary in FH patie...
...FH I, FH II and HIGH FH alirocumab studies and the RUTHERFORD-2 evolocumab study exclusively recruited patients with het...
...fh and a large laser spot size. However, with one TDTR measurement at fh, the uncertainty of the TDTR measurement is usu...
...FH cases. Median age was 44.0 years (45.9% men) and 40 years (46.6% men) in FH patients and unaffected relatives (P<0.00...
...FH, AIIS, GT, ASIS, PSIS, IT, IC, and SP; (female) LT, TRC, AIIS, FH, GT, ASIS, PSIS, IT, IC, and SP. Female ossificatio...
...FH) when altering the treatment regimen from weekly LDL apheresis to bi-weekly evolocumab treatment.,Three patients with...
...FH). In this study, we directly delivered exogenous Ldlr gene into the liver of FH model mice (Ldlr(-/-)) by lentiviral ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
